While it is not known if semaglutide has the same effect in humans, people with a personal or family history of medullary thyroid carcinoma, or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), should not use semaglutide
This approval means the treatment met rigorous safety and efficacy standards verified by independent review
Retrieved from Lasikiewicz, N., Myrissa, K., Hoyland, A., et al
"Carnitine for valproic acid toxicity." Clin Toxicol 2009;47:101-11
Oral semaglutide must be taken daily on an empty stomach with a small amount of water, and patients need to wait at least 30 minutes before consuming any food or other medications
Cardiovasc Drugs Ther 1998;12:291-9